Description
Rydapt (midostaurin) is a multi-targeted kinase inhibitor used for FLT3-mutated AML and advanced systemic mastocytosis.
$17,706.18
Multi-kinase inhibitor for leukemia
Rydapt (midostaurin) is a multi-targeted kinase inhibitor used for FLT3-mutated AML and advanced systemic mastocytosis.
Reviews
There are no reviews yet.